$870k in unpaid invoices... hmmmmm.
Maybe that's a clue as to why this company, which allegedly has $16-26m in yearly sales, is considering merging with an OTC company that, thanks to auditor problems, is delinquent and will have to restate a couple years of filings.
Couple all that with the private company also needing to undergo a proper audit, and the chances of this merger ever finalizing begin to look rather slim.